$35.61
-1.75-4.68%
At close: -
$35.25
-0.36-1.01%
After Hours: 4:32 PM EDT
Comments
Loading...
Apogee Therapeutics Insider Trading Activity | NASDAQ:APGE | Benzinga
Track the latest Apogee Therapeutics insider trading activity. Stay informed on recent buys, sells, and market impact for Apogee Therapeutics stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Apogee Therapeutics Inc Insiders Doing?
At Apogee Therapeutics Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of 11.59K shares worth $349.97K, meanwhile, insiders have report no purchases in the last 30 days.
Notable Recent Insider Buys and Sales
- On March 7, 2025, Carl Dambkowski, the company's CHIEF MEDICAL OFFICER sold 1.59K shares for $30.48 each.
- On February 7, 2025, Carl Dambkowski, the company's CHIEF MEDICAL OFFICER sold 2.73K shares for $31.77 each.
- On January 3, 2025, Carl Dambkowski, the company's CHIEF MEDICAL OFFICER sold 2.73K shares for $34.9 each.
Ownership Statistics for Apogee Therapeutics Inc
Shares Outstanding
56.903M
Insider Shares Owned
1.846M
Insider Percentage Owned
3.24%
Institutional Shares Held
26.907M
Institutional Percentage Held
46.3%
| Mar 07, 2025 | Carl Dambkowski | CHIEF MEDICAL OFFICER | -1.59K | $30.48 | -$48.46K | SELL | -0.63% | 251.03K | Mar 05 | View |
| Mar 07, 2025 | Michael Henderson | CHIEF EXECUTIVE OFFICER | -10.00K | $30.15 | -$301.51K | SELL | -0.77% | 1.29M | Mar 05 | View |
| Feb 07, 2025 | Carl Dambkowski | CHIEF MEDICAL OFFICER | -2.73K | $31.77 | -$125.06K | SELL | -1.07% | 252.62K | Feb 05 | View |
| Feb 07, 2025 | Michael Henderson | CHIEF EXECUTIVE OFFICER | -15.00K | $40.58 | -$608.70K | SELL | -1.14% | 1.30M | Feb 05 | View |
| Jan 10, 2025 | Michael Henderson | CHIEF EXECUTIVE OFFICER | -15.00K | $48.85 | -$732.69K | SELL | -1.13% | 1.31M | Jan 08 | View |
| Jan 03, 2025 | Carl Dambkowski | CHIEF MEDICAL OFFICER | -2.73K | $34.90 | -$160.65K | SELL | -1.06% | 255.35K | Jan 02 | View |
| Dec 16, 2024 | Mark McKenna | DIRECTOR | 20.00K | $49.54 | $990.77K | BUY | ∞ | 20.00K | Dec 12 | View |
| Dec 13, 2024 | Carl Dambkowski | CHIEF MEDICAL OFFICER | -2.73K | $35.81 | -$179.87K | SELL | -1.04% | 258.07K | Dec 11 | View |
| Dec 06, 2024 | Carl Dambkowski | CHIEF MEDICAL OFFICER | -6.67K | $46.07 | -$307.06K | SELL | -2.49% | 260.80K | Dec 04 | View |
| Dec 06, 2024 | Michael Henderson | CHIEF EXECUTIVE OFFICER | -15.00K | $46.58 | -$698.65K | SELL | -1.12% | 1.32M | Dec 04 | View |
| Nov 08, 2024 | Carl Dambkowski | CHIEF MEDICAL OFFICER | -6.67K | $59.12 | -$394.04K | SELL | -2.43% | 267.46K | Nov 06 | View |
| Nov 08, 2024 | Michael Henderson | CHIEF EXECUTIVE OFFICER | -15.00K | $59.22 | -$888.32K | SELL | -1.11% | 1.34M | Nov 06 | View |
| Oct 04, 2024 | Carl Dambkowski | CHIEF MEDICAL OFFICER | -6.67K | $56.26 | -$374.95K | SELL | -2.37% | 274.13K | Oct 02 | View |
| Oct 04, 2024 | Michael Henderson | CHIEF EXECUTIVE OFFICER | -40.00K | $56.23 | -$2.25M | SELL | -2.87% | 1.35M | Oct 02 | View |
| Sep 06, 2024 | Carl Dambkowski | CHIEF MEDICAL OFFICER | -6.67K | $47.56 | -$316.97K | SELL | -2.32% | 280.79K | Sep 04 | View |
| Sep 06, 2024 | Michael Henderson | CHIEF EXECUTIVE OFFICER | -40.00K | $47.62 | -$1.90M | SELL | -2.79% | 1.39M | Sep 04 | View |
| Aug 23, 2024 | Jane Henderson | CHIEF FINANCIAL OFFICER | -6.00K | $48.26 | -$289.56K | SELL | -2.90% | 200.87K | Aug 23 | View |
| Aug 09, 2024 | Carl Dambkowski | CHIEF MEDICAL OFFICER | -7.33K | $40.67 | -$298.34K | SELL | -2.49% | 287.46K | Aug 07 | View |
| Aug 09, 2024 | Michael Henderson | CHIEF EXECUTIVE OFFICER | -40.00K | $40.62 | -$1.62M | SELL | -2.71% | 1.43M | Aug 07 | View |
| Jul 05, 2024 | Michael Henderson | CHIEF EXECUTIVE OFFICER | -15.00K | $37.26 | -$558.90K | SELL | -1.01% | 1.47M | Jul 05 | View |
| Jul 05, 2024 | Carl Dambkowski | CHIEF MEDICAL OFFICER | -6.00K | $37.60 | -$225.42K | SELL | -1.99% | 294.79K | Jul 03 | View |
| Jul 17, 2023 | Nimish Shah | DIRECTOR | 1.75M | $17.00 | $29.75M | BUY | ∞ | 1.75M | Jul 13 | View |
| Jul 17, 2023 | Fairmount Funds Management LLCFairmount Healthcare Fund LPFairmount Healthcare Fund II LPFairmount Healthcare CoInvest II LPTomas KiselakEvan Peter Harwin | DIRECTOR | 2.94M | $17.00 | $50.00M | BUY | ∞ | 892.53K | Jul 13 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.
APGE Insider Trading News
No news found